EVENTS · MDT
PEERS
EARNINGS
Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and healthcare solutions. Its portfolio spans cardiovascular care, neuroscience, medical surgical products, and diabetes management, supporting the diagnosis, treatment, and monitoring of a wide range of chronic and complex conditions. Medtronic supplies hospitals, clinics, physicians, and other healthcare providers with products such as cardiac rhythm devices, neuromodulation systems, surgical instruments, insulin pumps, and patient monitoring technologies. The company serves healthcare systems across the United States and international markets, making it an important participant in modern medical device supply chains and clinical care delivery. Headquartered in Dublin, Ireland, Medtronic plc focuses on technologies used in everyday care and advanced procedures, helping healthcare professionals address conditions across many specialties.
No company news, with medical device stocks higher as a group and peers like LivaNova and Zimmer Biomet also up
| Series | 1W | 1M |
|---|---|---|
| MDT | +10.7% | +20.5% |
| Peers | +4.4% | +12.9% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 85 | 91 |
Agreed to be acquired by MiniMed Group, Inc. Similar stock deals closed 85% of the time (n=515), typically 158 days after announcement, around Feb 19, 2027 for this one.
The company is offering to repurchase its own shares in a tender offer; holders choose whether to tender.
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q1 FY2027 | 1.40 | 1.45 | +3.45% | — |
| Q4 FY2026 | 1.56 | 1.55 | −0.43% | — |
| Q3 FY2026 | 1.35 | 1.36 | +0.89% | — |
| Q2 FY2026 | 1.33 | 1.36 | +2.43% | — |
| Series | 1W | 1M |
|---|---|---|
| MDT | +10.7% | +20.5% |
| Peers | +4.4% | +12.9% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 85 | 91 |
